Recently, HIF-2 inhibition- resistant ccRCC patient-derived xenograft tumors were found to have high HIF1A levels, raising the question whether HIF1α indeed played a tumor promoting/resistance-conferring role in these ccRCC tumors43. This evidence concerns the gene HIF1A and neoplasm.